All News

Advanced age, prolonged use of non-invasive ventilation (NIV), and unsuccessful response to NIV are independent predictors for long-term mortality in chronic obstructive pulmonary disease (COPD), according to a recent report.

Ruxolitinib plus etanercept showed positive results for the treatment of steroid-refractory severe acute graft-versus-host disease.

Secukinumab 150 mg improves signs and symptoms of patients with nonradiographic axial spondyloarthritis, according to results of the PREVENT trial published in Arthritis & Rheumatology.

In individuals under the age of 50, both total body obesity and abdominal obesity were associated with greater migraine prevalence and attack frequency, according to a study published in The Journal of Headache and Pain.

The prevalence of such sleep disorders as narcolepsy and obstructive sleep apnea increased appreciably from 2013 to 2016. It is unknown whether this is due to increased awareness or increased incidence.

Although the effects of stress and anger on ischemic heart disease and arrhythmia are well known, they are less established in heart failure, particularly those with reduced ejection fraction.

New guidelines from the American College of Physicians and the American Academy of Family Physicians are cautioning providers against treating patients with acute pain from musculoskeletal injuries with opioids.

An HHS report outlines efforts to reduce kidney failure and increase options such as home-based dialysis. COVID-19 has made kidney care a higher priority.

Findings published in JAMA Network Open show ICD-10 codes perform poorly in capturing COVID-19-related symptoms, highlighting the critical need for meticulous data validation to feed multicenter registries built from electronic medical records.

The Adjuvant Platinum and Taxane in Triple-Negative Breast Cancer trial investigated this combination adjuvant treatment vs the standard-of-care anthracycline plus docetaxel among patients with operable disease.

An investigation into the use of fingolimod as antiretroviral therapy against HIV-1 revealed 2 potential targets for the immunosuppressive drug: S1P receptors and SAMHD1, an antiviral restriction factor.

A community oncology practice network and a cancer genomics firm announced an initiative to expand opportunities for real-time precision medicine as well as research participation.

Satralizumab is the third drug to be approved by the FDA for neuromyelitis optica spectrum disorder (NMOSD).

Individuals with recent-onset type 2 diabetes (T2D) accompanied by weight loss have a high risk for developing pancreatic cancer, according to a study published in JAMA Oncology.

There was an almost 99% increase in the 1-year survival rate among candidates on the United Network for Organ Sharing waitlist for a heart transplant between 1987-1990 and 2011-2017.

A study published in JAMA Ophthalmology found that as of April 30, 2020, most practices were complying with American Academy of Ophthalmology (AAO) guidelines for scheduling patients during the pandemic.

Officials from health care and manufacturing predict ongoing shortages of personal protective equipment (PPE); the FDA authorized use of a saliva test for coronavirus disease 2019 (COVID-19); 1 in 3 Americans will not take a COVID-19 vaccine.

A higher number of headache-free days (HFDs) is associated with decreased headache-related disability among individuals with migraine, according to a study published in the Journal of Managed Care & Specialty Pharmacy.

An agreement will tap Caris Life Sciences' next-generation sequencing technology to identify patients for Merus’ phase 1/2 eNRGy trial.

Fewer off-target effects mean second-generation BTK inhibitors offer less cardiotoxicity and allow patients to stay on them longer, increasing their efficacy.

Investigators have made tremendous strides improving patient care in multiple myeloma (MM), but the authors of a new review article say much more work is needed.

Oncology drug costs affect those entering into risk-based arrangements, and these groups must rethink their approach to evaluating risk.

Proposed CMS rules would make it easier for state Medicaid programs to smooth the way for value-based contracts for high-cost gene therapies.

A long-term study of over 46 million Medicare beneficiaries found that emergency department (ED) visits for acute respiratory illnesses such as asthma or COPD sharply increased in the days before a major thunderstorm.

Compared with non-invasive ventilation (NIV), high-flow nasal cannula (HFNC) oxygen therapy carried less risk of treatment failure and had better tolerance and comfort among patients.

A new study of patients with rheumatoid arthritis (RA) in Korea has shown that only about half of patients with RA who attained clinical remission were also in imaging remission.

Patients with chronic lymphocytic leukemia (CLL) often face months or years of uncertainty. A new study might help those patients better understand their progression timeline.

A new rule makes it impossible for patients with end-stage renal disease (ESRD) to take part in Medicare Advantage, leaving them out of coordinated care.